Preprint · CC-BY
via OpenAlex
Canagliflozin extends life span and leads to less weight gain in C57BL6 male mice
Evagelia E Habeos, Fotini Filippopoulou, Menelaos G. Kanakis, George I. Habeos, George Lagoumintzis, Stavros L. Taraviras, Dionysios V. Chartoumpekis
bioRxiv (Cold Spring Harbor Laboratory) · 2022
Abstract
ABSTRACT SGLT2 inhibitors are widely prescribed drugs for type 2 diabetes and heart failure. It seems that their beneficial health effects are multifaceted and not only limited to the amelioration of glycemic profile. It is suggested that SGLT2 inhibitors-induced glycosuria causes a metabolic shift that mimics the fasting response. It is also known that calorie restriction leads to enhanced longevity in mice. Thus, we hypothesized that long-term treatment of mice with SGLT2 inhibitors might extend their life span. To this end male C57BL6 mice at the age of 4 months were put on a normal chow diet or on a diet supplemented with 200 mg/kg canagliflozin. The canagliflozin-treated mice showed lower body weight gain over time and increased life span. The median survival of control mice was 107.5 weeks, while that of the canagliflozin-treated group was 112.5 weeks (p=0.011). No difference was seen in the presence or severity of cataracts. This study showed for the first time an enhanced median survival of canagliflozin-treated male mice with a homogeneous genetic background (C57BL6). Further analyses are in progress to elucidate the metabolic adaptations and mechanisms underlying this effect.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1101/2022.11.20.517248
- Canonical
- link ↗
- Fetched
- 2026-10-12 MST
Cite this
APA
Habeos, E.E., Filippopoulou, F., Kanakis, M.G., Habeos, G.I., Lagoumintzis, G., Taraviras, S.L., & Chartoumpekis, D.V. (2022). Canagliflozin extends life span and leads to less weight gain in C57BL6 male mice. <em>bioRxiv (Cold Spring Harbor Laboratory)</em>. https://doi.org/10.1101/2022.11.20.517248
Vancouver
Habeos EE, Filippopoulou F, Kanakis MG, Habeos GI, Lagoumintzis G, Taraviras SL, et al. Canagliflozin extends life span and leads to less weight gain in C57BL6 male mice. bioRxiv (Cold Spring Harbor Laboratory). 2022. doi:10.1101/2022.11.20.517248.
BibTeX
@unpublished{evagelia2022Canagl,
title = {Canagliflozin extends life span and leads to less weight gain in C57BL6 male mice},
author = {Evagelia E Habeos and Fotini Filippopoulou and Menelaos G. Kanakis and George I. Habeos and George Lagoumintzis and Stavros L. Taraviras and Dionysios V. Chartoumpekis},
journal = {bioRxiv (Cold Spring Harbor Laboratory)},
year = {2022},
doi = {10.1101/2022.11.20.517248},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
bioRxiv (Cold Spring Harbor Laboratory) 2021
Preprint · CC-BY
Sexual Dimorphic Metabolic and Cognitive Responses of C57BL/6 Mice to Fisetin or Dasatinib and Quercetin Cocktail Oral Treatment
Aging 2010
Open access · CC-BY
Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv mice
The Lancet Child & Adolescent Health 2018
Citation only
The age of adolescence
Aging Cell 2014
Open access · CC-BY
Maternal caloric restriction partially rescues the deleterious effects of advanced maternal age on offspring
GeroScience 2023
Open access · CC-BY
Sexual dimorphic metabolic and cognitive responses of C57BL/6 mice to Fisetin or Dasatinib and quercetin cocktail oral treatment
The Journals of Gerontology Series A 2006
Open access · OA